Source: Rounding the Earth Author:Mathew Crawford


It’s not my style to point to the explanations of others without doing my own thinking, but there are times when that makes the most economical sense.

The primary purpose of this post is to talk you into watching Dr. Pierre Kory explain both the case that ivermectin (IVM) effectively prevents or treats COVID-19, and also how and why that information is withheld by public health officials. He said nothing at all I have reason to disagree with, but what he says is sharp and will shock some people.

It is also certainly the case that, after reading thousands of pages of evidence, talking to hundreds of doctors, researchers, and other smart people about hydroxychloroquine (HCQ), I know far more about the HCQ story during the pandemic. So, I write more about HCQ. But I am not partisan regarding what medical treatment works the best in fighting COVID-19.

And having spent time with raw data of a multidrug protocol that used both HCQ and IVM, I feel most connected to the idea that doctors should be encouraged to use these and other medicines as they see fit, and in particular early during disease progression.

That said, it is most important to understand how health officials are treating each drug. The two stories together are more than enough to push me over the point of a perspective that assumes good faith. It is crucially important that these stories are well understood by as many people as possible because there is a need to identify the kunlangeta, and perhaps find the best way to take the initiative prior to what seems to be shaping up to be a far larger friction in world events than I think most people recognize at this stage.

Related: How much proof do you want? Hundreds of studies conclude – treat Covid-19 early with hydroxychloroquine!

Journal of Medicine Says HCQ + Zinc Reduces COVID Deaths

HCQ Peer-reviewed: Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection

The Chloroquine Wars: Part I

The Chloroquine Wars Part II

The Chloroquine Wars Part III

The Chloroquine Wars Part IV

The Chloroquine Wars Part V – A Closer Look at RCTs Studying Hydroxychloroquine Efficacy

The Chloroquine Wars Part VI – The Simple Logic of the Hydroxychloroquine Hypothesis

The Chloroquine Wars, Part VII – Why Did Dr. Anthony Fauci Leave Hydroxychloroquine Off the Early Pandemic Research Priority List?

The Chloroquine Wars Part VIII – Hydroxychloroquine’s Safety Profile and a Cost-Benefit Analysis

The Chloroquine Wars Part IX – How Research Can be Rigged by Statistically Stacking the Deck (A Simpson’s Paradox Tale)

The Chloroquine Wars Part X – A Discussion of the Insanity of the Chloroquine Wars

The Chloroquine Wars Part XI – See No Good, Hear No Good, Speak No Good

The Chloroquine Wars Part XII – Manufactured Fear During Hydroxychloroquine’s Trump Moment

The Chloroquine Wars Part XIII -A Clockwork Orange Man

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

The Chloroquine Wars Part XVII – Why the Story About India’s April COVID-19 Spike is All Wrong

The Chloroquine Wars Part XV – How to Rig Research: Surgisphere Part II

The Chloroquine Wars Part XIX – Historical Failures of Public Health Authorities

The Chloroquine Wars Part XX – Why The Early Treatment Data is Better Than Anyone Imagines

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

A Conversation With Dr. Brian Tyson – The Chloroquine Wars Part XLI

The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.

Read More »

Dr. Brian Tyson, USA: Hydroxychloroquine – Data, Strategies and Success Treating over 6000 Covid Patients

We continue to delve extensively into the COVID-19 data with esteemed statistician, Mathew Crawford. In this episode, we take a closer look at the use of early treatment and its success. Mathew has been researching the data from Dr. Brian Tyson, who has successfully treated over 6000 patients who contracted COVID throughout the pandemic. It is my great honor to have Dr. Tyson here on this episode to not only discuss the data, but also the strategies that he has been using throughout the pandemic.

Read More »